Figure 3.

Kaplan-Meier estimates for time to death after ICI initiation stratified by ICI-P status. The P value for the log-rank test for differences between ICI-P status is shown (middle right), along with median survival (days) for patients with ICI-P and control participants without ICI-P (bottom table). Of 285 patients, 30 were excluded because of unknown vital status (resulting from loss to follow-up). Censoring occurred on the day of chart extraction if patient was living. Median survival is reported in days. Event = death; ICI = immune checkpoint inhibitor; ICI-P = immune checkpoint inhibitor-related pneumonitis.